Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
E-pub ahead of print

Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarction

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Prognostic value of automated pupillometry: an unselected cohort from a cardiac intensive care unit

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Survival of patients with and without diabetes following out-of-hospital cardiac arrest: A nationwide Danish study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Optimised care of elderly patients with acute coronary syndrome

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

BACKGROUND: Cardiogenic shock complicating ST-elevation myocardial infarction is characterised by progressive left ventricular dysfunction causing inflammation and neurohormonal activation. Often, cardiogenic shock develops after hospital admission. Whether inflammation and a neurohormonal activation precede development of clinical cardiogenic shock is unknown.

METHODS AND RESULTS: In 93% of 2247 consecutive patients with suspected ST-elevation myocardial infarction admitted at two tertiary heart centres, admission plasma levels of pro-atrial natriuretic peptide, copeptin, mid-regional pro-adrenomedullin and stimulation-2 were measured on hospital admission. Patients were stratified according to no cardiogenic shock development and cardiogenic shock developed before (early cardiogenic shock) or after (late cardiogenic shock) leaving the catheterization laboratory. In total, 225 (10%) patients developed cardiogenic shock, amongst these patients late cardiogenic shock occurred in 64 (2.9%). All four biomarkers were independently associated with the development of late cardiogenic shock (odds ratio per two-fold increase in risk: 1.19-3.13) even when adjusted for the recently developed Observatoire Régional Breton sur l'Infarctus risk score for prediction of late cardiogenic shock development. Furthermore, pro-atrial natriuretic peptide, copeptin and mid-regional pro-adrenomedullin, but not stimulation-2, added significant predictive information, when added to the Observatoire Régional Breton sur l'Infarctus risk score (area under the receiver-operating characteristic curve, pro-atrial natriuretic peptide: 0.87, p=0.0008; copeptin: 0.86, p<0.05; mid-regional pro-adrenomedullin: 0.88, p=0.006).

CONCLUSIONS: Pro-atrial natriuretic peptide, copeptin, mid-regional pro-adrenomedullin and stimulation-2 admission plasma concentration were associated with late cardiogenic shock development in patients admitted with suspected ST-elevation myocardial infarction. Pro-atrial natriuretic peptide, mid-regional pro-adrenomedullin and copeptin had independent predictive value for late cardiogenic shock development.

Original languageEnglish
JournalEuropean Heart Journal: Acute Cardiovascular Care
Pages (from-to)2048872619896063
ISSN2048-8726
DOIs
Publication statusE-pub ahead of print - 21 Jan 2020

ID: 59439515